Literature DB >> 21070990

Stage IVA thymoma: patterns of spread and surgical management.

Cameron D Wright1.   

Abstract

Stage IVA disease can be de novo disease or more commonly represent recurrent disease. The pleura is the most common site of relapse after thymoma resection. Local pleural disease is usually simply resected. This is usually combined with either induction or adjuvant chemotherapy. The ultimate extended surgery for advanced thymic tumors is an extrapleural pneumonectomy done for extensive pleural disease. This rarely performed operation is done for both stage IVA disease found at initial presentation and for recurrent disease as a salvage procedure. Again, these advanced patients with pleural spread are probably best managed by induction chemotherapy followed by resection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21070990     DOI: 10.1016/j.thorsurg.2010.08.007

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  5 in total

1.  Role of Surgery in the Treatment of Masaoka Stage IVa Thymoma.

Authors:  Erkan Kaba; Berker Ozkan; Suat Erus; Salih Duman; Berk Cimenoglu; Alper Toker
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-12-08       Impact factor: 1.520

2.  Comparing the safety and efficacy of thoracoscopic surgery and thoracotomy for thymoma: a systematic review and meta-analysis.

Authors:  Ling Lv; Wenya Li; Wanfu Men; Zhenghua Liu; Chenggang Jiang
Journal:  Gland Surg       Date:  2021-12

3.  Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project.

Authors:  Bernhard Moser; Elie Fadel; Dominique Fabre; Shaf Keshavjee; Marc de Perrot; Pascal Thomas; Geoffrey Brioude; Dirk Van Raemdonck; Sophie Viskens; Loic Lang-Lazdunski; Andrea Bille; Walter Weder; Wolfgang Jungraithmayr; Enrico Ruffini; Francesco Guerrera; David Gómez de Antonio; Moishe Liberman; Nuria Novoa; Marco Scarci; Stefan Janik; Walter Klepetko
Journal:  Eur J Cardiothorac Surg       Date:  2017-08-01       Impact factor: 4.191

4.  Optimal management of thymic malignancies: current perspectives.

Authors:  Gabrielle Drevet; Stéphane Collaud; François Tronc; Nicolas Girard; Jean-Michel Maury
Journal:  Cancer Manag Res       Date:  2019-07-22       Impact factor: 3.989

5.  Robotic thoracic surgery for resection of thymoma and tumors of the thymus: technical development and initial experience.

Authors:  Ricardo Mingarini Terra; José Ribas Milanez-de-Campos; Rui Haddad; Juliana Rocha Mol Trindade; Leticia Leone Lauricella; Benoit Jacques Bibas; Paulo Manuel Pêgo-Fernandes
Journal:  J Bras Pneumol       Date:  2019-12-13       Impact factor: 2.624

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.